Arax Advisory Partners’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.08K Hold
1,216
– – ﹤0.01% 5010
2026
Q2
$2.75K Buy
+1,216
New +$3.11K ﹤0.01% 4742

Other funds holding TCRT

Arax Advisory Partners's TCRT Position: Q3 2026 in Review

Arax Advisory Partners held its Alaunos Therapeutics (TCRT) position steady in Q3 2026 at 1,216 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #5010.

Arax Advisory Partners first reported a position in TCRT in Q2 2026 and has held it in 2 quarters since. The position peaked at $2.75K in Q2 2026. 24 funds tracked by Wall St. Rank hold TCRT as of Q3 2026.

  • Arax Advisory Partners held 1,216 shares of Alaunos Therapeutics worth $1.08K as of Q3 2026.
  • Arax Advisory Partners left its Alaunos Therapeutics share count unchanged in Q3 2026.
  • Alaunos Therapeutics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #5010 holding.
  • Arax Advisory Partners first reported a position in Alaunos Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • Arax Advisory Partners's Alaunos Therapeutics position peaked at $2.75K in Q2 2026.
  • 24 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.